Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 107.3 USD 0.45% Market Closed
Market Cap: 21.4B USD
Have any thoughts about
Zimmer Biomet Holdings Inc?
Write Note

Zimmer Biomet Holdings Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zimmer Biomet Holdings Inc
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Zimmer Biomet Holdings Inc
NYSE:ZBH
Pre-Tax Income
$1B
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
0%
Becton Dickinson and Co
NYSE:BDX
Pre-Tax Income
$2B
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Pre-Tax Income
$2.2B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
36%
Stryker Corp
NYSE:SYK
Pre-Tax Income
$4.2B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
14%
Abbott Laboratories
NYSE:ABT
Pre-Tax Income
$6.8B
CAGR 3-Years
-6%
CAGR 5-Years
12%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Pre-Tax Income
$2.4B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
15%
No Stocks Found

Zimmer Biomet Holdings Inc
Glance View

Market Cap
21.4B USD
Industry
Health Care
Economic Moat
None

Zimmer Biomet Holdings Inc. stands as a prominent player in the medical device industry, specializing in musculoskeletal healthcare. Emerging from a rich legacy that dates back to its origins in the early 20th century, the company has carved out its niche by innovating in the orthopedic reconstruction sector. Zimmer Biomet operates primarily through designing, manufacturing, and marketing a comprehensive range of orthopedic products, which include joint replacement implants, such as knees, hips, and shoulders, as well as products used for fracture fixation and bone growth stimulation. The innovative edge of Zimmer Biomet lies in its commitment to improving patient outcomes and enhancing the quality of life through advanced surgical and robotic technologies. The company invests significantly in R&D to maintain its competitive edge, constantly pushing the boundaries in personalized solutions and minimally invasive surgery. The company generates revenue by selling its orthopedic and surgical products directly to hospitals, surgical centers, and healthcare providers worldwide. Zimmer Biomet's business model is heavily reliant on the relationships it builds with orthopedic surgeons and healthcare institutions, positioning itself as an essential partner in delivering sophisticated solutions for musculoskeletal health. By focusing on comprehensive, integrated solutions, Zimmer Biomet not only addresses the immediate surgical needs but also engages with the continuum of care in rehabilitation and patient recovery. The company’s strategic acquisitions, sophisticated product pipeline, and global market presence enable it to capture a significant share of the medical device market, ensuring its role as a stalwart in transforming the future of healthcare.

ZBH Intrinsic Value
153.23 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Zimmer Biomet Holdings Inc's Pre-Tax Income?
Pre-Tax Income
1B USD

Based on the financial report for Sep 30, 2024, Zimmer Biomet Holdings Inc's Pre-Tax Income amounts to 1B USD.

What is Zimmer Biomet Holdings Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
0%

Over the last year, the Pre-Tax Income growth was 46%. The average annual Pre-Tax Income growth rates for Zimmer Biomet Holdings Inc have been 10% over the past three years .

Back to Top